Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Timing matters with Zero Based Budgeting. This guide highlights scenarios and cues to start applying strategies for best impact in changing finances.
20,192 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A major Taiwan chipmaker plans to double the size of its Arizona facility, a move Trump touts as a potential steeplec...
Meta Platforms is weighing a bold move into prediction markets, boosting investor interest and triggering a rally. An...
Looking for a single artificial intelligence stock hold to ride AI-era gains for 10 years? This guide explains why Al...
Palantir’s stock bounces back in early July after a rough June, with analysts pointing to AI-led growth and renewed d...
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
UBS researchers say infrastructure stocks have overtaken hyperscalers in AI spending, signaling a shift in AI infrast...
Two insurance giants reveal how revenue trends shape investor returns. This guide breaks down who earns more, where p...
Six Dividend Aristocrats inside SCHD provide ballast for the fund as markets remain volatile. Here’s who leads the in...
Prediction-market traders are pricing a US edge after Balogun’s clearance to play in the World Cup round-of-16. Marke...
A speculative analysis explores a spacex-tesla merger valued at $3.4 trillion and explains why such a mega-deal might...
Sophisticated AI can imitate voices and faces, turning ordinary messages into lifelike scams. This guide explains dee...